Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 1976-1987

  Cronin, L ^a   Guyatt, G ^a   Griffith, L ^a   Wong, E ^a   Azziz, R ^c   Futterweit, W ^d   Cook, D ^a   Dunaif, A ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DEMOGRAPHY; FACTORIAL ANALYSIS; FEMALE; HUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; BODY WEIGHT; EDUCATIONAL STATUS; EMOTIONS; ETHNIC GROUPS; FEMALE; HIRSUTISM; HUMANS; INFERTILITY, FEMALE; MARITAL STATUS; MENSTRUATION DISTURBANCES; OBESITY; OCCUPATIONS; POLYCYSTIC OVARY SYNDROME; QUALITY OF LIFE; QUESTIONNAIRES;

FALLOPIA;

EID: 0031764171     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.6.1976     Document Type: Article

References (44)

1. Polson DW, Wadsworth J, Adams J, Franks S. 1988 Polycystic ovaries - a common finding in normal women. Lancet. 1:870-872.
2. Dunaif A, Givenes JR, Haseltine F, Merriam GR. 1992 The polycystic ovary syndrome. Cambridge, Massachusetts: Blackwell Scientific.
3. Dahlgren E, Janson PO. 1994 Polycystic ovary syndrome: long-term metabolic consequences. Int J Gynecol Obstet. 44:3-8.
4. Franks S. 1995 Polycystic ovary syndrome. N Engl J Med. 333:853-861.
5. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 65:499-507.
6. Dunaif A, Futterweit W, Segal KR, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome. Diabetes. 38:1165-1174.
7. Conway GS, Honour JW, Jacobs HS. 1989 Heterogeneity of the polycystic ovary syndrome: clinical, endocrine, and ultrasound features in 556 patients. Clin Endocrinol (Oxf). 30:459-470.
8. Dahlgren E, Johansson S, Lindstedt G, et al. 1992 Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril. 57:505-513.
9. Mechanick J, Dunaif A. 1990 Hirsutism. Trends in endocrinology and metabolism. March/April:185-188.
10. Dunaif A. 1997 Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocr Rev. 18:774-800.
11. Hull MGR. 1987 Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol. 1:235-245.
12. Carmina E, Koyama T, Chang L, et al. 1992 Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol. 167:1807-12.
13. Ferriman D, Gallwey JD. 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 21:1440-1447.
14. Sonino N, Fava GA, Mani E, et al. 1993 Quality of life of hirsute women. Postgrad Med J. 69:186-189.
15. Paulson JD, Haarmann BS, Salerno RL, Asmar P. 1988 An investigation of relationship between emotional maladjustment and infertility. Fertil Steril. 49:258-262.
16. Downey J, Husami N, Yingling S, et al. 1989 Mood disorders, psychiatric symptoms, and distress in women presenting for infertility evaluation. Fertil Steril. 52:425-432.
17. Grieco A, Long CJ. 1984 Investigation of the Karnofsky Performance status as a measure of quality of life. Health Psychol. 3:129-142.
18. Bergner M, Bobbit RA, Carter WB, Gilson BS. 1981 The Sickness impact profile: development and final revision of health status measure. Med Care. 19:787-805.
19. Andrews FM, Withey SB. 1976 Social indicators of well-being: Americans' perception of life quality. New York: Plenum Press.
20. Morrow GR, Chiarello RJ, Derogates LR. 1978 A new scale for assessing patients' psychosocial adjustment to medical illness. Psychol Med. 8:605-610.
21. Brazier JE, Harper R, Jones NM, et al. 1992 Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Brit Med J. 305:160-164.
22. Ware JE, Sherboume CD. 1992 The MOS 36 item short-form health survey (SF-36). Med Care. 30:473-483.
23. Jenkinson C, Coulter A, Wright L. 1993 Short form health-survey questionnaire: normative data for adults of working age. Brit Med J. 306:1437-1440.
24. Garratt AM, Ruta DA, Abdalla MI, et al. 1993 The SF 36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? Brit Med J. 306:1440-1444.
25. Kirchner B, Guyatt GH. 1985 A methodologic framework for assessing health indices. J Chron Dis. 38:27-36.
26. Guyatt GH, Bombardier C, Tugwell PX. 1986 Measuring disease-specific quality of life in clinical trials. Can Med Assoc J. 134:889-895.
27. Juniper EF, Guyatt GH, Streiner DL, King DR. 1997 Clinical sensibility vs. factor analysis for questionnaire construction: Pediatrics. J Clin Epidemiol. 50:233-238.
28. Guyatt GH, Norgradi S, Halcrow S, Singer J, Sullivan MJJ, Fallen EL. 1989 Development and testing of a new measure of health status for clinical trial in heart failure. J Gen Intern Med. 4:101-107.
29. Guyatt GH, Mitchel A, Irving EJ, Singer J, Goodacre R, Tompkins C. 1989 A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 98:804-810.
30. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. 1987 A measure of quality of life for clinical trials in chronic lung disease. Thorax. 42:773-778.
31. Levine MN, Guyatt GH, Gent M, De Pauws S, Goodyear MD. 1988 Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol. 6:1798-1810.
32. Juniper EF, Guyatt GH. 1991 Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 21:77-83.
33. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. 1993 Measuring quality of life in asthma. Am Rev Respir Dis. 147:468-479.
34. Guyatt GH, Eagle DJ, Sackett B, et. al. 1993 Development and testing of a questionnaire to measure quality of life in the frail elderly. J Clin Epidemiol. 46:1433-1444.
35. Hillers T, Guyatt GH, Oldrige N, et al. 1994 Quality of life after myocardial infarction. J Clin Epidemiol. 47:1287-1296.
36. Juniper EF, Guyatt GH, Dolovich J. 1994 Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol. 93:413-423.
37. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. 1996 Measuring quality of life in children with asthma. Quality of Life Research. 5:35-46.
38. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. 1996 Measuring quality of life in the parents of children with asthma. Quality of Life Research. 5:27-34.
39. Osteoporosis Quality of Life Study Group. Measuring quality of life in women with osteoporosis. Osteoporosis International. In press.
40. Feinstein AR. 1987 Clinimetrics. New Haven: Yale University Press.
41. Jaeschke R, Guyatt G, Keller J, Singer J. 1989 Measurement of health status: ascertaining the meaning of a change in quality-of-life questionnaire score. Controlled Clin Trials. 10:407-415.
42. Juniper EF, Guyatt GH, Willan A, Griffith LE. 1994 Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 47:81-87.
43. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhino conjunctivitis quality of life questionnaire data. J Allergy Clin Immunol. In press.
44. Redelmeier DA, Goldstein RS, Guyatt GH. 1996 Assessing the minimal important difference in symptoms: a comparison of techniques. J Clin Epidemiol. 49:1215-1219.